Fingerprint
Dive into the research topics of 'Targeting Glycoprotein NMB With Antibody-Drug Conjugate, Glembatumumab Vedotin, for the Treatment of Osteosarcoma'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Targeting Glycoprotein NMB With Antibody-Drug Conjugate, Glembatumumab Vedotin, for the Treatment of Osteosarcoma
Michael Roth, David M. Barris, Sajida Piperdi, Vicky Kuo, Stephanie Everts, David Geller, Peter Houghton, E. Anders Kolb, Thomas Hawthorne, Jonathan Gill, Richard Gorlick
Research output: Contribution to journal › Article › peer-review
48
Scopus
citations